BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6342200)

  • 1. Purification of urokinase from complex mixtures using immobilized monoclonal antibody against urokinase light chain.
    Vetterlein D; Calton GJ
    Thromb Haemost; 1983 Feb; 49(1):24-7. PubMed ID: 6342200
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of urokinase-type plasminogen activator (u-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies.
    Darras V; Thienpont M; Stump DC; Collen D
    Thromb Haemost; 1986 Dec; 56(3):411-4. PubMed ID: 3105111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
    Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
    Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinase.
    Wojta J; Kirchheimer JC; Turcu L; Christ G; Binder BR
    Thromb Haemost; 1986 Jun; 55(3):347-51. PubMed ID: 3092391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies monospecific to single-chain urokinase-type plasminogen activator (scu-PA).
    Scheuerlein JG; Kalies I; Gluth WP; Kalden JR
    Hybridoma; 1991 Jun; 10(3):395-9. PubMed ID: 1916850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of monoclonal antibodies in the diagnosis of fibrinolysis].
    Wojta J; Korninger C; Kirchheimer J; Hattey E; Turcu L; Binder BR
    Wien Klin Wochenschr; 1985 Mar; 97(5):244-8. PubMed ID: 4039506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
    Astedt B; Lecander I; Brodin T; Lundblad A; Löw K
    Thromb Haemost; 1985 Feb; 53(1):122-5. PubMed ID: 3922076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Purification of human urokinase and its topographical localisation in renal parenchyma.
    Andrassy K; Ritz E; Bleyl U; Egbring R
    Thromb Diath Haemorrh; 1975 Sep; 34(1):338. PubMed ID: 1237948
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification of urokinase by a beta-naphthamidine affinity column.
    Astedt B; Holmberg L; Wagner G; Richter P; Ploug J
    Thromb Haemost; 1979 Oct; 42(3):924-8. PubMed ID: 505406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies against urokinase.
    Hérion P; Glineur C; Franssen JD; Urbain J; Bollen A
    Biosci Rep; 1981 Nov; 1(11):885-92. PubMed ID: 7030431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a monoclonal antibody against human urokinase: development of a competitive ELISA for urokinase antigen.
    Nakamura M; Ogawa H; Tsunematsu T
    Nihon Ketsueki Gakkai Zasshi; 1987 Feb; 50(1):158-67. PubMed ID: 2438892
    [No Abstract]   [Full Text] [Related]  

  • 12. Physicochemical properties of highly purified kidney cultured plasminogen activator (single chain urokinase).
    Sumi H; Kosugi T; Matsuo O; Mihara H
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):119-28. PubMed ID: 7051725
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification of urokinase by monoclonal antibody affinity chromatography.
    Hérion P; Bollen A
    Biosci Rep; 1983 Apr; 3(4):373-9. PubMed ID: 6347270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid isolation of high molecular weight urokinase from native human urine.
    Huber K; Kirchheimer J; Binder BR
    Thromb Haemost; 1982 Jun; 47(3):197-202. PubMed ID: 7051408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
    Rijken DC; Wijngaards G; Welbergen J
    J Lab Clin Med; 1981 Apr; 97(4):477-86. PubMed ID: 6782183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and some properties of urokinase.
    Ogawa N; Yamamoto H; Katamine T; Tajima H
    Thromb Diath Haemorrh; 1975 Sep; 34(1):194-209. PubMed ID: 242089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin.
    Grøndahl-Hansen J; Ralfkiaer E; Nielsen LS; Kristensen P; Frentz G; Danø K
    J Invest Dermatol; 1987 Jan; 88(1):28-32. PubMed ID: 3098860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation (agar zone electrophoresis) and immunological characterisation of urokinase.
    Andrassy K; Ritz E
    Thromb Haemost; 1977 Aug; 38(2):536-44. PubMed ID: 579494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of urokinase by affinity chromatography.
    Holmberg L; Bladh B; Astedt B
    Biochim Biophys Acta; 1976 Aug; 445(1):215-22. PubMed ID: 953032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to human urokinase identify the single-chain pro-urokinase precursor.
    Salerno G; Verde P; Nolli ML; Corti A; Szöts H; Meo T; Johnson J; Bullock S; Cassani G; Blasi F
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):110-4. PubMed ID: 6364130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.